ATRC
Price
$22.61
Change
-$0.44 (-1.91%)
Updated
Apr 25, 6:59 PM EST
6 days until earnings call
CERS
Price
$1.70
Change
+$0.04 (+2.41%)
Updated
Apr 25, 6:59 PM EST
7 days until earnings call
Ad is loading...

ATRC vs CERS ᐉ Comparison: Which is Better to Invest?

Header iconATRC vs CERS Comparison
Open Charts ATRC vs CERSBanner chart's image
AtriCure
Price$22.61
Change-$0.44 (-1.91%)
Volume$167.45K
CapitalizationN/A
Cerus
Price$1.70
Change+$0.04 (+2.41%)
Volume$482.9K
CapitalizationN/A
View a ticker or compare two or three
ATRC vs CERS Comparison Chart

Loading...

ATRCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CERSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ATRC vs. CERS commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Hold and CERS is a Buy.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (ATRC: $23.05 vs. CERS: $1.66)
Brand notoriety: ATRC and CERS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATRC: 56% vs. CERS: 35%
Market capitalization -- ATRC: $1.45B vs. CERS: $342.62M
ATRC [@Medical Specialties] is valued at $1.45B. CERS’s [@Medical Specialties] market capitalization is $342.62M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.42B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 0 FA rating(s) are green whileCERS’s FA Score has 0 green FA rating(s).

  • ATRC’s FA Score: 0 green, 5 red.
  • CERS’s FA Score: 0 green, 5 red.
According to our system of comparison, CERS is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 4 TA indicator(s) are bullish while CERS’s TA Score has 3 bullish TA indicator(s).

  • ATRC’s TA Score: 4 bullish, 3 bearish.
  • CERS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ATRC is a better buy in the short-term than CERS.

Price Growth

ATRC (@Medical Specialties) experienced а -1.71% price change this week, while CERS (@Medical Specialties) price change was +1.22% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.48%. For the same industry, the average monthly price growth was -0.49%, and the average quarterly price growth was +16.66%.

Reported Earning Dates

ATRC is expected to report earnings on Jul 30, 2024.

CERS is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Medical Specialties (+3.48% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ATRC with price predictions.
OPEN
A.I.dvisor published
a Summary for CERS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ATRC($1.45B) has a higher market cap than CERS($343M). CERS YTD gains are higher at: -23.148 vs. ATRC (-35.416). ATRC has higher annual earnings (EBITDA): -8.11M vs. CERS (-26.34M). ATRC has more cash in the bank: 137M vs. CERS (65.9M). ATRC has less debt than CERS: ATRC (74.5M) vs CERS (96M). ATRC has higher revenues than CERS: ATRC (399M) vs CERS (156M).
ATRCCERSATRC / CERS
Capitalization1.45B343M422%
EBITDA-8.11M-26.34M31%
Gain YTD-35.416-23.148153%
P/E Ratio36.76N/A-
Revenue399M156M256%
Total Cash137M65.9M208%
Total Debt74.5M96M78%
FUNDAMENTALS RATINGS
ATRC vs CERS: Fundamental Ratings
ATRC
CERS
OUTLOOK RATING
1..100
646
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9297
PRICE GROWTH RATING
1..100
8960
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (49) in the Medical Specialties industry is in the same range as ATRC (67). This means that CERS’s stock grew similarly to ATRC’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ATRC (100). This means that CERS’s stock grew similarly to ATRC’s over the last 12 months.

ATRC's SMR Rating (92) in the Medical Specialties industry is in the same range as CERS (97). This means that ATRC’s stock grew similarly to CERS’s over the last 12 months.

CERS's Price Growth Rating (60) in the Medical Specialties industry is in the same range as ATRC (89). This means that CERS’s stock grew similarly to ATRC’s over the last 12 months.

ATRC's P/E Growth Rating (94) in the Medical Specialties industry is in the same range as CERS (100). This means that ATRC’s stock grew similarly to CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCCERS
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
ATRCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CERSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLRYX43.35-0.04
-0.09%
SEI Large Cap Growth Y (SIMT)
HSWCX16.69-0.02
-0.12%
Hartford Schroders International Stk C
GIDAX7.21-0.01
-0.14%
Goldman Sachs Intl Eq Div & Prem A
RYRAX43.38-0.20
-0.46%
Rydex Retailing H
IRFCX8.46-0.08
-0.94%
Cohen & Steers International Realty C

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with VCYT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
-0.52%
VCYT - ATRC
49%
Loosely correlated
+0.35%
PEN - ATRC
46%
Loosely correlated
+0.22%
KIDS - ATRC
46%
Loosely correlated
+1.86%
TFX - ATRC
45%
Loosely correlated
+0.03%
QTRX - ATRC
44%
Loosely correlated
-0.37%
More